Crossmark

Dual clinical utility of cholesterol, high density lipoprotein, and glucose index: from advanced cardiovascular-kidney-metabolic syndrome pathogenesis to inflammatory-mediated mortality across early-transitional stages

Crossref DOI link: https://doi.org/10.1186/s13098-025-02055-2

Published Online: 2025-12-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Benjie

Wang, Qixian

Yu, Zhuoxuan

Zhang, Yujun

Song, Jingjing

Xie, Chunfeng

Zhao, Jingyang

Liu, Xinxin

Jie, Zhigang

Zhang, Guoyang
Funding

Funding for this research was provided by:

the “Talent 555 Project” of Jiangxi Province (700238003)
License Information

Text and Data Mining valid from 2025-12-13

Version of Record valid from 2026-01-19
More Information

Article History

Received: 26 May 2025

Accepted: 6 December 2025

First Online: 13 December 2025

Declarations

:

: Relevant institutional review boards approved data sources, and no additional ethical approval was needed for this study. This study was conducted in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below